PlainRecalls
FDA Devices Moderate Class II Terminated

Vysis CLL FISH Probe Kit with the following components: Vysis LSI p53 SpectrumOrange/ATM, SpectrumGreen and LSI D13S319, SpectrumOrange/ 13q34, SpectrumAqua/CEP 12 SpectrumGreen Probes

Reported: October 6, 2021 Initiated: August 4, 2021 #Z-2576-2021

Product Description

Vysis CLL FISH Probe Kit with the following components: Vysis LSI p53 SpectrumOrange/ATM, SpectrumGreen and LSI D13S319, SpectrumOrange/ 13q34, SpectrumAqua/CEP 12 SpectrumGreen Probes

Reason for Recall

Potential for Vysis CLL FISH Probe Kits not detecting 13q deletions in known positive patient samples.

Details

Recalling Firm
Abbott Molecular, Inc.
Units Affected
186 units
Distribution
Worldwide distribution - US Nationwide distribution in the states of AZ, CA, FL, GA, IL, IN, KY, MI, MN, MA, NC, NJ, NM, NY, OH, PA, TN, TX, UT, VA, VT, WA, WI and the countries of Australia, Belgium, Brazil, Canada, China, Costa Rica, Czech Republic, Estonia, Germany, Hong Kong, Israel, Italy, Kazakhstan, Netherlands, Philippines, Poland, Saudi Arabia, Slovenia, South Africa, South Korea, Spain, United Kingdom, Uruguay.
Location
Des Plaines, IL

Frequently Asked Questions

What product was recalled?
Vysis CLL FISH Probe Kit with the following components: Vysis LSI p53 SpectrumOrange/ATM, SpectrumGreen and LSI D13S319, SpectrumOrange/ 13q34, SpectrumAqua/CEP 12 SpectrumGreen Probes. Recalled by Abbott Molecular, Inc.. Units affected: 186 units.
Why was this product recalled?
Potential for Vysis CLL FISH Probe Kits not detecting 13q deletions in known positive patient samples.
Which agency issued this recall?
This recall was issued by the FDA Devices on October 6, 2021. Severity: Moderate. Recall number: Z-2576-2021.